Publication of Prospectus
London listing expansion could lift TSXV:AMRQ liquidity and interest over the next 3-12 months.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
London listing expansion could lift TSXV:AMRQ liquidity and interest over the next 3-12 months.
What happened and why it matters
Amaroq announced FCA approval of a prospectus for admission to the UK Official List and London Main Market, with AIM trading ending July 30 and Main Market trading starting July 31, 2026. No new shares are being issued, and AMRQ will keep its ISIN CA02311U1030. The cross-list aims to broaden liquidity and investor access to Amaroq’s Greenland assets, including Nalunaq.
Cross-market admission typically improves liquidity and investor interest for a cross-listed issuer; TSXV:AMRQ could see near-term price support from increased visibility and potential arbitrage dynamics.
Amaroq to list on London Main Market July 31, 2026; AIM trading ends July 30.
No new shares issued; existing ISIN CA02311U1030; AMRQ ticker remains.
FCA-approved prospectus published; admission to Official List and Main Market confirmed.
Cross-listing may improve liquidity and attract global investors for TSXV AMRQ.
Nalunaq Gold Mine and Greenland assets underpin company value and catalysts.
Category: Corporate Developments. This is a capital markets/migration update signaling broader liquidity access and strategic visibility beyond operations.
More AI-analyzed coverage connected to this story